Aster Insights (Formerly M2GEN) is a leading oncology-focused bioinformatics solutions company advancing precision medicine and transforming cancer care through clinical and molecular data and analytics tools. Aster Insights is the only bioinformatics company that has lifetime, patient-consented longitudinal clinical data, coupled with WES and WTS sequencing, for both tumor and germline data. Aster Insight's ORIEN members are NCI-Designated cancer centers that gather de-identified and lifetime-consented clinical and genomic patient data for research purposes, enabling collaborative discovery.